Levodopa EP Impurity A
데이터 정확도 100%
연중무휴 과학적 지원
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

27244-64-0Levodopa EP Impurity A

● 재고 있음

카탈로그 번호:VE006138
CAS 번호:27244-64-0
분자식:C9H11NO5
분자량:213.06

에 대한 추가 정보 CAS 27244-64-0

모약물

Levodopa

IUPAC명

(2S)-2-Amino-3-(2, 4, 5-trihydroxyphenyl)propanoic acid;

약전 동의어

Levodopa Related Compound A

Other Synonyms

2-Hydroxy Levodopa; 2,5-Dihydroxy-L-tyrosine; 2,4,5-trihydroxyphenyl-L-alanine; 3-(3,4,6-Trihydroxyphenyl)-L-alanine; L-Tyrosine, 2,5-dihydroxy-(9CI)

SMILES

C1=C(C(=CC(=C1O)O)O)C[C@@H](C(=O)O)N

InChI

InChI=1S/C9H11NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,11-13H,1,10H2,(H,14,15)/t5-/m0/s1

설명

Levodopa EP Impurity A known in pharmacopoeias as Levodopa Related Compound A is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Levodopa. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. Also known as Levodopa Related Compound A, it is inhibitors of dopa decarboxylase, which is used to treat the symptoms of Parkinson’s disease.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form